Is This a Crackdown — or a Reset? Where Healthcare Scrutiny Is Going Next (And What It Means for Owners)
What’s happening in healthcare right now isn’t random.
And it’s not temporary.
It’s a shift.
Over the last 12–18 months, you’ve seen the headlines:
Fraud takedowns
Payment suspensions
Entire clusters of providers getting flagged
Most people read that and think:
“This is about bad operators.”
That’s not the full picture.
This is about how the system is changing — and who gets caught in it next.
The 3 Pressure Points Regulators Are Watching
Let’s simplify this.
If you strip away all the noise, enforcement right now is focused on three things:
Billing.
Licensing.
Referrals.
That’s it.
1. Billing Patterns
This is the easiest entry point for regulators.
Because it’s all data.
They’re not starting with site visits anymore.
They’re starting with:
Outlier billing patterns
Utilization spikes
Inconsistent service ratios
Example: Large-scale healthcare fraud takedowns have relied heavily on identifying abnormal billing trends across providers.
Source: https://oig.hhs.gov/newsroom/media-materials/2025-national-health-care-fraud-takedown/
If your numbers don’t “look right” — even if they are right — you get flagged.
And once you’re flagged, everything else gets looked at.
2. Licensing + Enrollment
This is where things have tightened significantly.
New providers are under more scrutiny than ever.
Not just:
“Do you have a license?”
But:
How did you get it?
Who’s behind the entity?
Is there overlap with other providers?
Example: Increased oversight has focused on provider enrollment and ownership transparency across healthcare sectors.
Source: https://www.wachler.com/articles/2025-articles-by-wachler-associates-pc/medicare-intensifies-oversight-of-hospices-amid-growing-fraud-concerns/
This is why you’re seeing:
Delays in approvals
Increased documentation requests
More frequent audits early in a provider’s lifecycle
3. Referral Relationships
This is the most sensitive — and most misunderstood.
It’s not just about illegal referrals.
It’s about patterns.
Who’s referring patients?
How concentrated is that?
Does it look “too consistent”?
Example: DOJ enforcement actions have increasingly targeted referral-based schemes and relationships across healthcare providers.
Source: https://www.dwt.com/insights/2025/07/doj-hhs-target-healthcare-industry-fca
Even if you’re clean — the optics matter.
And in this environment, optics get attention.
The Next 12 Months: Where Scrutiny Is Going
This is where most people are behind.
They’re reacting to what just happened.
Not where it’s going.
Here’s where this moves next:
Home Health
This is the most obvious.
Similar reimbursement structure to hospice
High utilization variability
Heavy reliance on documentation
And we’re already seeing signals.
Example: Industry warnings suggest fraud activity is shifting from hospice into home health and adjacent services.
Source: https://homehealthcarenews.com/2026/04/fraud-migrating-from-hospice-to-home-health-witness-warns-congress/
Personal Care / Non-Medical
This is a sleeper.
Why?
High volume
Lower barriers to entry
Less clinical oversight
That combination attracts both:
operators
and attention
Behavioral Health
Already under pressure in certain markets.
Rapid expansion
Insurance billing complexity
Private equity involvement
All things regulators watch closely.
Telehealth
This one’s already in motion.
COVID-era expansion
Loosened restrictions
Now tightening back down
Example: Telehealth-related fraud investigations have increased following rapid pandemic-era growth.
Source: https://www.armstrongbradylyons.com/library/hospice-fraud-investigation-defense
So What Is This Really?
A crackdown?
Or a reset?
It’s a reset.
Because what’s happening isn’t just enforcement.
It’s a redefinition of acceptable risk in the system.
Here’s What That Means for You
If you’re an operator, this is where it gets real.
Because this environment changes:
How buyers look at your business
How deals get structured
How risk gets priced
Clean isn’t enough anymore
Before:
If you weren’t committing fraud → you were fine
Now:
If you look risky → you get discounted
Documentation becomes valuation
Buyers are asking:
Can this hold up in an audit?
Is billing consistent?
Are referrals diversified?
That directly impacts:
multiples
terms
structure
Timing matters more than ever
Because:
You don’t want to sell:
right after your industry gets hit
But you also don’t want to wait:
until scrutiny expands further
That window matters.
Real Example (What This Looks Like in a Deal)
We’ve seen situations where:
Same business
Same revenue
Same EBITDA
But:
One buyer sees risk → lowers valuation, adds structure
Another buyer sees platform potential → pays up
The difference?
How they interpret:
compliance
documentation
exposure
Nothing else changed.
The Bigger Shift
This is where most people miss it.
Over time:
Weak operators get pushed out
Margins stabilize
Quality becomes scarce
And when quality becomes scarce:
👉 Good businesses become more valuable — not less
Final Thought
This isn’t about fear.
It’s about positioning.
Because in this market:
The wrong buyer sees risk
The right buyer sees value
And that gap?
That’s where deals are made.
If you’re trying to understand how your business actually looks through this lens — not just internally, but from a buyer and regulatory standpoint — that’s the kind of work Jake at AcquireCare spends time on with healthcare owners.
Because this market isn’t just about performance anymore.
It’s about how that performance holds up under scrutiny.
And that’s what ultimately drives outcomes.
